Perrigo Company (LSE:0Y5E), (NYSE:PRGO) is a player in the healthcare sector, focused on providing over-the-counter (OTC) health and wellness solutions. Its operations span across the development, manufacture, and distribution of self-care products and generic pharmaceuticals, aimed at improving the well-being of consumers. With a portfolio that includes dietary supplements, infant formulas, and topical medications, Perrigo is dedicated to making quality healthcare accessible and affordable. The company's projects are geared towards innovation in health and wellness, aiming to expand its product offerings while adhering to rigorous safety and efficacy standards. Perrigo’s objective is to lead in the self-care market by continually adapting to consumer health needs through research, development, and strategic acquisitions.